Judy is a partner on the bio investing team. She focuses on early stage companies in digital health and bioengineering.
Prior to joining Andressen Horowitz, Judy worked on synthetic biology research with Professors Adam Arkin and John Dueber at UC Berkeley, where she engineered organisms to produce high value pharmaceuticals and developed methods for improving these organisms using high throughput genome sequencing strategies. Before picking up her first pipette, Judy published several research projects in the computational modeling and simulation of neuronal networks.
Judy holds a BS in Computational Biology from the School of Computer Science at Carnegie Mellon. She studied for an MPhil in Plant Sciences from Cambridge University under a Churchill Scholarship. Judy completed her PhD in Bioengineering in the Joint UCSF-UC Berkeley Bioengineering Program, where she was awarded NDSEG and Hertz Fellowships to fund her research. While at Berkeley, Judy was also selected as a Mayfield Entrepreneurial Fellow.